Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Big Books & Bold Ideas with Kerri Miller
Kerri Miller and Kelly Gordon

Why CRISPR gene editing could be the future of medicine

A patient lies in a bed surrounded by medical equipment.
A patient lies in a bed before treatment in Berlin, Germany. Researchers announced recently they successfully used CRISPR injected directly into the bloodstream to treat a genetic disease. It’s being hailed as a major milestone for patients.
Theo Heimann | Getty Images 2013

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Last week, researchers announced they successfully used CRISPR injected directly into the bloodstream to treat a genetic disease. It’s being hailed as a major milestone for patients, and heralds the day when CRISPR — an innovative gene-editing technique that allows for precise changes to DNA — is used to treat other genetic diseases like muscular dystrophy, cystic fibrosis and cancer.

CRISPR works like a pair of genetic scissors. If researchers can identify a genetic defect inside a living cell, they can use CRISPR to cut that spot and either delete, repair or replace the affected gene.

But that same power has the potential for harm. In 2019, a Chinese doctor ended up in prison after he used CRISPR to create the world’s first gene-edited babies. Bioethicists warn that CRISPR should be used cautiously, lest scientists accidentally transform the human race.

Tuesday, host Kerri Miller spoke with one of the pioneers of CRISPR and a bioethicist who specializes in the ethics of genetic modification.

Guests:

  • Alexis Komor is a professor of chemistry and biochemistry at the University of California, San Diego and the lead researcher at the Komor Lab.

  • Jeffrey Kahn is the Andreas C. Dracopoulos director of the Johns Hopkins Berman Institute of Bioethics and a professor of bioethics and public policy in the Department of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health.

To listen to the full conversation you can use the audio player above.

Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS